MMR vaccination and disease elimination: the Finnish experience (Q30226989)

11 June 2017

title

MMR vaccination and disease elimination: the Finnish experience (English)

1 reference

11 June 2017

0 references

Irja Davidkin

1

1 reference

11 June 2017

Mia Kontio

series ordinal

2

1 reference

11 June 2017

Mikko Paunio

series ordinal

3

1 reference

11 June 2017

Heikki Peltola

series ordinal

4

1 reference

11 June 2017

publication date

1 September 2010

1 reference

Expert Review of Vaccines

11 June 2017

published in

1 reference

11 June 2017

volume

9

1 reference

11 June 2017

issue

9

1 reference

11 June 2017

page(s)

1045-1053

1 reference

Rapid effect on endemic measles, mumps, and rubella of nationwide vaccination programme in Finland

11 June 2017

cites work

1 reference

The elimination of indigenous measles, mumps, and rubella from Finland by a 12-year, two-dose vaccination program

21 January 2018

1 reference

Explosive school-based measles outbreak: intense exposure may have resulted in high risk, even among revaccinees

21 January 2018

1 reference

Twice vaccinated recipients are better protected against epidemic measles than are single dose recipients of measles containing vaccine

21 January 2018

1 reference

Secondary measles vaccine failures identified by measurement of IgG avidity: high occurrence among teenagers vaccinated at a young age.

21 January 2018

1 reference

Measles, mumps, and rubella in Finland: 25 years of a nationwide elimination programme

21 January 2018

1 reference

Rubella immunity and morbidity: impact of different vaccination programs in Finland 1979-1992.

21 January 2018

1 reference

Frequency of true adverse reactions to measles-mumps-rubella vaccine. A double-blind placebo-controlled trial in twins

21 January 2018

1 reference

Day-to-day reactogenicity and the healthy vaccinee effect of measles-mumps-rubella vaccination

21 January 2018

1 reference

No evidence for measles, mumps, and rubella vaccine-associated inflammatory bowel disease or autism in a 14-year prospective study.

21 January 2018

1 reference

Persistence of anti-mumps virus antibodies after a two-dose MMR vaccination. A nine-year follow-up

21 January 2018

1 reference

Vaccine-induced measles virus antibodies after two doses of combined measles, mumps and rubella vaccine: a 12-year follow-up in two cohorts

21 January 2018

1 reference

Persistence of measles, mumps, and rubella antibodies in an MMR-vaccinated cohort: a 20-year follow-up

21 January 2018

1 reference

Mumps virus-specific antibody titers from pre-vaccine era sera: comparison of the plaque reduction neutralization assay and enzyme immunoassays

21 January 2018

1 reference

Comparison of plaque reduction neutralisation test (PRNT) and measles virus-specific IgG ELISA for assessing immunogenicity of measles vaccination

21 January 2018

1 reference

Cellular immunity to mumps virus in young adults 21 years after measles-mumps-rubella vaccination

21 January 2018

1 reference

Mumps resurgences in the United States: A historical perspective on unexpected elements

21 January 2018

1 reference

Recent resurgence of mumps in the United States

21 January 2018

1 reference

Mumps outbreak in a highly vaccinated student population, The Netherlands, 2004.

21 January 2018

1 reference

Measles outbreak in a highly vaccinated population, San Diego, 2008: role of the intentionally undervaccinated

21 January 2018

1 reference

The cost of containing one case of measles: the economic impact on the public health infrastructure--Iowa, 2004.

21 January 2018

1 reference

Long-lasting measles outbreak affecting several unrelated networks of unvaccinated persons.

21 January 2018

1 reference

Waning antibodies in measles and rubella vaccinees--a longitudinal study.

21 January 2018

1 reference

Persistence of rubella antibodies after 2 doses of measles-mumps-rubella vaccine.

21 January 2018

1 reference

Modelling antibody response to measles vaccine and subsequent waning of immunity in a low exposure population.

21 January 2018

1 reference

IgG avidity to distinguish secondary from primary measles vaccination failures: prospects for a more effective global measles elimination strategy

21 January 2018

1 reference

Measles in Europe: an epidemiological assessment

21 January 2018

1 reference

Measles elimination in the United States

21 January 2018

1 reference

Early waning of maternal measles antibodies in era of measles elimination: longitudinal study

21 January 2018

1 reference

Mumps vaccine performance among university students during a mumps outbreak

21 January 2018

1 reference

Mumps outbreaks in Canada and the United States: time for new thinking on mumps vaccines

21 January 2018

1 reference

Mumps outbreaks in vaccinated populations: are available mumps vaccines effective enough to prevent outbreaks?

21 January 2018

1 reference

Modelling measles re-emergence as a result of waning of immunity in vaccinated populations

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ERV.10.99

1 reference

11 June 2017

1 reference